Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer
Sarah A. Best, Patrick M. Gubser, Shalini Sethumadhavan, et al.
Cell Metabolism (2022) Vol. 34, Iss. 6, pp. 874-887.e6
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Amino acid metabolism in health and disease
Zhenan Ling, Yifan Jiang, Jun-Nan Ru, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 181
SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity
Chuansheng Guo, Zhiyuan You, Hao Shi, et al.
Nature (2023) Vol. 620, Iss. 7972, pp. 200-208
Open Access | Times Cited: 120
Squamous cell lung cancer: Current landscape and future therapeutic options
Sally C. M. Lau, Yuanwang Pan, Vamsidhar Velcheti, et al.
Cancer Cell (2022) Vol. 40, Iss. 11, pp. 1279-1293
Open Access | Times Cited: 91
Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer
Maria Zagorulya, Leon Yim, Duncan M. Morgan, et al.
Immunity (2023) Vol. 56, Iss. 2, pp. 386-405.e10
Open Access | Times Cited: 86
Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective
Jieyu Liu, Yinan Bai, Yinggang Li, et al.
EBioMedicine (2024) Vol. 107, pp. 105301-105301
Open Access | Times Cited: 73
Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
Zhen Zeng, Minyang Fu, Yuan Hu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 56
Next batter up! Targeting cancers with KRAS-G12D mutations
Mara N. Zeissig, Lauren M. Ashwood, Olga Kondrashova, et al.
Trends in cancer (2023) Vol. 9, Iss. 11, pp. 955-967
Open Access | Times Cited: 43
Unveiling the role of KRAS in tumor immune microenvironment
Miao Xu, Xing Zhao, Ti Wen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116058-116058
Open Access | Times Cited: 24
A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle
Bolin Wang, Jinli Pei, Shengnan Xu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 23
Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy
Yangkai Zhou, Jing Yuan, Ke Xu, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 1846-1864
Closed Access | Times Cited: 20
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer
Ray Pillai, Sarah E. LeBoeuf, Yuan Hao, et al.
Science Advances (2024) Vol. 10, Iss. 13
Open Access | Times Cited: 19
13 C metabolite tracing reveals glutamine and acetate as critical in vivo fuels for CD8 T cells
H. Eric, Michael S. Dahabieh, Lisa M. DeCamp, et al.
Science Advances (2024) Vol. 10, Iss. 22
Open Access | Times Cited: 16
Immunometabolism of CD8+ T cell differentiation in cancer
Hao Shi, Sidi Chen, Hongbo Chi
Trends in cancer (2024) Vol. 10, Iss. 7, pp. 610-626
Closed Access | Times Cited: 15
Cancer cells co-opt nociceptive nerves to thrive in nutrient-poor environments and upon nutrient-starvation therapies
Yu Zhang, Chengzhong Lin, Zheqi Liu, et al.
Cell Metabolism (2022) Vol. 34, Iss. 12, pp. 1999-2017.e10
Open Access | Times Cited: 68
Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks
Ke Xu, Jie Ma, Sean R. R. Hall, et al.
Theranostics (2023) Vol. 13, Iss. 2, pp. 704-723
Open Access | Times Cited: 37
Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer
Kexun Zhou, Shuo Li, Yi Zhao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Mechanisms of CD8+ T cell exclusion and dysfunction in cancer resistance to anti-PD-(L)1
Keywan Mortezaee, Jamal Majidpoor
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114824-114824
Open Access | Times Cited: 24
Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer
Qiming Zhou, Yao Peng, Fenfen Ji, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
The role of mitochondria in the resistance of melanoma to PD-1 inhibitors
Fei Du, Lu-han Yang, Jiao Liu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Glutamine metabolic competition drives immunosuppressive reprogramming of intratumour GPR109A+myeloid cells to promote liver cancer progression
Yang Yang, Tianduo Pei, Chaobao Liu, et al.
Gut (2024), pp. gutjnl-332429
Closed Access | Times Cited: 11
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
Kun Huang, Ying Han, Yihong Chen, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Metabolites and Immune Response in Tumor Microenvironments
Salvatore Cortellino, Valter D. Longo
Cancers (2023) Vol. 15, Iss. 15, pp. 3898-3898
Open Access | Times Cited: 17
KEAP1 promotes anti-tumor immunity by inhibiting PD-L1 expression in NSCLC
Jinghan Li, Daiwang Shi, Siyi Li, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 6
Unlocking the potential of T‐cell metabolism reprogramming: Advancing single‐cell approaches for precision immunotherapy in tumour immunity
Lihaoyun Huang, Haitao Li, Cangang Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 6
Glutamine Metabolism and Prostate Cancer
Holger H.H. Erb, Nikita Polishchuk, Oleh Stasyk, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2871-2871
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top